You are here

AusPAR: Olaparib

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

30 October 2019
AusPAR Details
AusPAR
Active Ingredient
Olaparib
Product Name
Lynparza
Sponsor
AstraZeneca Pty Ltd
Submission Number
PM-2017-01451-1-4
Submission Type
Extension of indications and major variation (strength and dosage form)
Decision
Approved
AusPAR Date
16 October 2019
Publication Date

30 October 2019